Guy R. Simpson

3.7k total citations
57 papers, 3.0k citations indexed

About

Guy R. Simpson is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Guy R. Simpson has authored 57 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 23 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Guy R. Simpson's work include Virus-based gene therapy research (29 papers), Cancer Research and Treatments (14 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Guy R. Simpson is often cited by papers focused on Virus-based gene therapy research (29 papers), Cancer Research and Treatments (14 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Guy R. Simpson collaborates with scholars based in United Kingdom, United States and Canada. Guy R. Simpson's co-authors include Thomas F. Schulz, Robin A. Weiss, Hardev Pandha, Georgina Platt, Shou‐Jiang Gao, Patrick S. Moore, Lucille Rainbow, Kevin J. Harrington, Pamela Cook and Alan Melcher and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Guy R. Simpson

56 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guy R. Simpson United Kingdom	26	1.8k	1.2k	923	664	643	57	3.0k
Paolo Monini Italy	36	2.3k 1.3×	1.5k 1.3×	1.0k 1.1×	162 0.2×	532 0.8×	99	3.6k
Mary Hummel United States	24	1.2k 0.7×	1.5k 1.2×	550 0.6×	300 0.5×	331 0.5×	46	2.5k
Katherine Staskus United States	22	1.4k 0.8×	1.5k 1.2×	994 1.1×	331 0.5×	652 1.0×	25	3.5k
David Rowe United States	37	3.7k 2.1×	1.6k 1.4×	1.4k 1.5×	713 1.1×	723 1.1×	88	4.9k
Nikolaus Mueller‐Lantzsch Germany	32	735 0.4×	881 0.7×	467 0.5×	312 0.5×	1.1k 1.7×	63	2.8k
Robert W. Atchison United States	22	1.7k 1.0×	1.1k 0.9×	725 0.8×	1.3k 1.9×	841 1.3×	50	3.6k
Ruth F. Jarrett United Kingdom	37	2.8k 1.6×	1.1k 0.9×	1.0k 1.1×	235 0.4×	749 1.2×	106	5.1k
Jun Komano Japan	24	697 0.4×	428 0.4×	618 0.7×	223 0.3×	816 1.3×	83	2.5k
J. H. Pope Australia	26	2.1k 1.2×	1.0k 0.8×	950 1.0×	465 0.7×	559 0.9×	70	3.4k
Andrew D. Hislop United Kingdom	37	2.4k 1.4×	1.9k 1.6×	570 0.6×	184 0.3×	398 0.6×	62	4.7k

Countries citing papers authored by Guy R. Simpson

Since Specialization

Citations

This map shows the geographic impact of Guy R. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy R. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy R. Simpson more than expected).

Fields of papers citing papers by Guy R. Simpson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy R. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy R. Simpson. The network helps show where Guy R. Simpson may publish in the future.

Co-authorship network of co-authors of Guy R. Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Guy R. Simpson. A scholar is included among the top collaborators of Guy R. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy R. Simpson. Guy R. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pandha, Hardev, et al.. (2023). Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysis by Coxsackie Virus A21. Methods in molecular biology. 2684. 319–327. 2 indexed citations

Rogers, William, Guy R. Simpson, Carla S. Möller‐Levet, et al.. (2022). HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme. BMC Cancer. 22(1). 400–400. 12 indexed citations

Annels, Nicola, Guy R. Simpson, Matt Coffey, et al.. (2020). Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors. Molecular Therapy — Oncolytics. 20. 434–446. 20 indexed citations

Elamin, Ayssar A., Wulf Oehlmann, Matthias Stehr, et al.. (2020). A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection. Frontiers in Oncology. 9. 1484–1484. 9 indexed citations

Annels, Nicola, David Mansfield, Carmen Ballesteros‐Merino, et al.. (2019). Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 25(19). 5818–5831. 97 indexed citations

Comins, Charles, Guy R. Simpson, William Rogers, et al.. (2018). Synergistic antitumour effects of rapamycin and oncolytic reovirus. Cancer Gene Therapy. 25(5-6). 148–160. 9 indexed citations

Annels, Nicola, Guy R. Simpson, Carla S. Möller‐Levet, et al.. (2018). Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus. Molecular Therapy — Oncolytics. 9. 1–12. 50 indexed citations

Sauer, Ursula, Andreas Heinzel, Paul Perco, et al.. (2016). Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer. Biomarkers. 22(7). 674–681. 19 indexed citations

Seth, Rohit, Aadil Khan, Michelle Wilkinson, et al.. (2015). Adenovirally Delivered Enzyme Prodrug Therapy with Herpes Simplex Virus–Thymidine Kinase in Composite Tissue Free Flaps Shows Therapeutic Efficacy in Rat Models of Glioma. Plastic & Reconstructive Surgery. 135(2). 475–487. 5 indexed citations

10.

Morgan, Richard, et al.. (2014). Targeting HOX transcription factors in prostate cancer. BMC Urology. 14(1). 17–17. 42 indexed citations

11.

Simpson, Guy R., András Horváth, Nicola Annels, et al.. (2012). Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. British Journal of Cancer. 106(3). 496–507. 28 indexed citations

12.

Wong, Joyce, Kaitlyn J. Kelly, Arjun Mittra, et al.. (2010). A Third-Generation Herpesvirus Is Effective Against Gastroesophageal Cancer. Journal of Surgical Research. 163(2). 214–220. 9 indexed citations

13.

Price, Daniel L., Shu‐Fu Lin, Guy R. Simpson, et al.. (2010). Oncolysis Using Herpes Simplex Virus Type 1 Engineered to Express Cytosine Deaminase and a Fusogenic Glycoprotein for Head and Neck Squamous Cell Carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 136(2). 151–151. 10 indexed citations

14.

Simpson, Guy R. & Robert S. Coffin. (2009). Construction and Characterization of an Oncolytic HSV Vector Containing a Fusogenic Glycoprotein and Prodrug Activation for Enhanced Local Tumor Control. Methods in molecular biology. 542. 551–564. 6 indexed citations

15.

Melbye, Mads, Pamela Cook, Henrik Hjalgrim, et al.. (1998). Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981–1996. International Journal of Cancer. 77(4). 543–548. 159 indexed citations

16.

Renwick, Neil, Teysir Halaby, Gerrit Jan Weverling, et al.. (1998). Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposiʼs sarcoma. AIDS. 12(18). 2481–2488. 162 indexed citations

17.

Simpson, Guy R., Thomas F. Schulz, Denise Whitby, et al.. (1996). Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. The Lancet. 348(9035). 1133–1138. 493 indexed citations

18.

Simpson, Guy R., Clive Patience, Roswitha Löwer, et al.. (1996). Endogenous D-Type (HERV-K) Related Sequences Are Packaged into Retroviral Particles in the Placenta and Possess Open Reading Frames for Reverse Transcriptase. Virology. 222(2). 451–456. 68 indexed citations

19.

Moore, John P., Guy R. Simpson, Jane A. McKeating, et al.. (1992). CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro. Virology. 188(2). 537–544. 13 indexed citations

20.

Simpson, Guy R., et al.. (1992). Retroviral pseudotypes produced by rescue of a moloney murine leukemia virus vector by C-type, but not D-type, retroviruses. Virology. 186(2). 792–794. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact